CompletedPhase 4ACTRN12611000555954
Efficacy of Silodosin in Expulsive Therapy of Lower Ureteral Stones: A Randomized Controlled trial
Efficacy of silodosin in expulsive therapy of lower ureteral stones
Sponsor
Chung Jing Wang
Enrollment
55 participants
Start Date
May 1, 2010
Study Type
Interventional
Conditions
Summary
perform a comparative study to evaluate the clinical role of silodosin in the medical expulsive therapy of symptomatic lower ureteral stones.
Eligibility
Sex: Both males and femalesMin Age: 20 YearssMax Age: 60 Yearss
Plain Language Summary
Simplified for easier understanding
This trial tests silodosin, a medication that relaxes the ureter muscle, as a way to help patients pass lower ureteral kidney stones larger than 5mm without surgery. The study compares silodosin to placebo to see whether the medication increases the chance of spontaneous stone passage and reduces pain episodes.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
silodosin (4 mg daily) orally for 2 weeks
silodosin (4 mg daily) orally for 2 weeks
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12611000555954